Faith Davies, M.D., MRCP, MRCPath, FRCPath
Faith Davies, M.D., MRCP, MRCPath, FRCPath
Deputy Director, Myeloma Institute; Director of Developmental Therapeutics; Director, Phase I Clinical Trials Program

Dr. Davies is recognized internationally for her focus on innovative targeted molecular therapies and her expertise in the treatment of relapsed and refractory disease. Profile

Frits van Rhee, M.D., Ph.D., MRCP, FRCPath
Frits van Rhee, M.D., Ph.D., MRCP, FRCPath
Director of Developmental and Translational Medicine

Dr. van Rhee’s research focuses on immunotherapy for myeloma. Dr. van Rhee is also a leading expert in Castleman Disease.Profile
Basic HTML supported. Line breaks automatically become new paragraphs.

Maurizio Zangari, M.D.

Maurizio Zangari, M.D.
Director of Myeloma Bone Disease Research

He is an internationally recognized expert in multiple myeloma with an extensive bibliography of peer-reviewed articles and invited presentations. Profile

Carolina Schinke, M.D.

Carolina Schinke, M.D.
Assistant Professor

Dr. Schinke completed advanced training in Hematology/Oncology at Montefiore Medical Center in New York City. Profile

Sharmilan Thanendrarajan, M.D.

Sharmilan Thanendrarajan, M.D.
Assistant Professor of Medicine

Dr. Thanendrarajan earned his medical degrees from Ruhr University Bochum in Germany. Profile